1. Home
  2. ETD vs NMRA Comparison

ETD vs NMRA Comparison

Compare ETD & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

HOLD

Current Price

$20.46

Market Cap

569.7M

ML Signal

HOLD

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

554.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETD
NMRA
Founded
1932
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
569.7M
554.0M
IPO Year
1996
2023

Fundamental Metrics

Financial Performance
Metric
ETD
NMRA
Price
$20.46
$1.80
Analyst Decision
Hold
Buy
Analyst Count
1
8
Target Price
$27.00
$7.50
AVG Volume (30 Days)
346.8K
1.5M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
8.15%
N/A
EPS Growth
N/A
5.23
EPS
1.10
N/A
Revenue
$766,784,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.73
N/A
P/E Ratio
$18.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.01
$0.66
52 Week High
$31.41
$3.65

Technical Indicators

Market Signals
Indicator
ETD
NMRA
Relative Strength Index (RSI) 32.50 33.38
Support Level N/A $1.53
Resistance Level $22.89 $1.90
Average True Range (ATR) 0.56 0.23
MACD -0.20 -0.02
Stochastic Oscillator 14.01 4.57

Price Performance

Historical Comparison
ETD
NMRA

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: